Literature DB >> 3158612

New trends on sweeteners in Japan.

I Takazoe.   

Abstract

Among the sweeteners available, the significance of disaccharides, especially, palatinose is emphasized from the point of view of the essential requirements sugar substitutes have to meet. Palatinose, an enzymatic derivative of sucrose, does not support the growth of cariogenic streptococci. Acid production by oral micro-organisms is quite weak, if at all. Polyglucan is not synthetized by S. mutans from palatinose. Furthermore, palatinose inhibits polyglucan synthesis from sucrose when added to it. Experiments in animals and man also indicate that palatinose is of low or no cariogenicity. Side effects of palatinose have not been recognized. In conclusion, palatinose is currently considered to be a promising sugar substitute.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158612

Source DB:  PubMed          Journal:  Int Dent J        ISSN: 0020-6539            Impact factor:   2.512


  4 in total

1.  Isomaltulose production using free cells: optimisation of a culture medium containing agricultural wastes and conversion in repeated-batch processes.

Authors:  Haroldo Y Kawaguti; Michele F Buzzato; Hélia H Sato
Journal:  J Ind Microbiol Biotechnol       Date:  2006-12-21       Impact factor: 3.346

2.  Immobilization of Sucrose Isomerase from Erwinia sp. with Graphene Oxide and Its Application in Synthesizing Isomaltulose.

Authors:  Feng Zhang; Xue Cai; Feng Cheng; Jia-Ming Yu; Bin Wang; Zhi-Qiang Liu; Yu-Guo Zheng
Journal:  Appl Biochem Biotechnol       Date:  2021-09-14       Impact factor: 2.926

3.  Tuning the catalytic performances of a sucrose isomerase for production of isomaltulose with high concentration.

Authors:  Feng Zhang; Feng Cheng; Dong-Xu Jia; Qian Liu; Zhi-Qiang Liu; Yu-Guo Zheng
Journal:  Appl Microbiol Biotechnol       Date:  2022-03-29       Impact factor: 4.813

Review 4.  Sugar Substitutes: Mechanism, Availability, Current Use and Safety Concerns-An Update.

Authors:  Megha Gupta
Journal:  Open Access Maced J Med Sci       Date:  2018-10-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.